Patent ID: 11911421
Assignee: GLAC BIOTECH CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method for alleviating type 1 diabetes mellitus (T1DM), comprising administering to a subject in need thereof a probiotic composition,
wherein the probiotic composition comprises Lactobacillus salivarius subsp. salicinius AP-32, Lactobacillus johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9, which are deposited at the China Center for Type Culture Collection (CCTCC) respectively under accession numbers CCTCC M 2011127, CCTCC M 2011128, and CCTCC M 2014588,
wherein a number ratio of Lactobacillus salivarius subsp. salicinius AP-32, Lactobacillus johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 ranges from 1:0.1:0.1 to 1:1:8, and
wherein the probiotic composition is in a dosage form for oral administration, and has a bacterial concentration of 1010 CFU/mL, and
wherein the subject is administered with the probiotic composition twice daily for a 6-month treatment period.